The effect of baicalein on angiogenic gene expression in lung cancer is further supported by data from two other NSCLC subtypes, both of which displayed a great number of gene alterations focused on angiogenesis and the VEGF signalling pathway following treatment with baicalein. Here, VEGFA is linked to non-small cell lung carcinoma.